Waters v. Secretary of Health and Human Services

CourtDistrict Court, W.D. Michigan
DecidedSeptember 21, 2022
Docket1:21-cv-00170
StatusUnknown

This text of Waters v. Secretary of Health and Human Services (Waters v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering District Court, W.D. Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Waters v. Secretary of Health and Human Services, (W.D. Mich. 2022).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

THERESE M. WATERS, on behalf of KELLY E. WATERS,

Plaintiff, Hon. Sally J. Berens

v. Case No. 1:21-cv-170

XAVIER BECERRA, Secretary, United States Department of Health & Human Services,

Defendant. ____________________________________/

OPINION Plaintiff, Therese M. Waters, on behalf of Kelly E. Waters, seeks judicial review pursuant to 42 U.S.C. §§ 405(g) and 1395ff(b)(1)(A) of a final decision of the Medicare Appeals Council denying Kelly’s claim for reimbursement under Medicare Part B for her orally-consumed enteral nutrition formula, Vitaflo Homocystinuria Cooler (HCU Cooler). This matter is now before the Court on the parties’ cross Motions for Summary Judgment.1 (ECF Nos. 29 and 31.) The motions are fully briefed and ready for decision. For the following reasons, the Court will grant the Secretary’s motion, deny Plaintiff’s motion, and affirm the Secretary’s final decision.2

1 Pursuant to 28 U.S.C. § 636(c), the parties have consented to have the Court conduct all further proceedings in this case, including entry of judgment. 2 Because Plaintiff requested oral argument only if Defendant did so, the Court will decide the matter on the briefs and the administrative record, as Defendant did not request oral argument. I. Background A. Kelly’s Genetic Disorder and the Medicare Claims Kelly, the Medicare beneficiary at issue in this matter, suffers from Homocystinuria (HCU), a rare condition that interferes with the body’s ability to break down protein from food that is consumed. More specifically, HCU is an inborn metabolic disease that prevents the body

from metabolizing the amino acid methionine. It also prevents the production of the amino acid L- cysteine, the end product of normally-metabolized methionine. (ECF No. 13 at PageID.301.) The disorder can lead to vision issues, brittle bones and other skeletal abnormalities, cognitive impairment and other mental abnormalities, and stroke. (Id.; see also PageID.304, 306.) Kelly, who is now an adult, was diagnosed with HCU at age 6. (Id. at PageID.303.) HCU is treated primarily through restricting the individual’s protein intake. (Id.) In addition to limiting Kelly’s protein intake, her treating physician prescribed HCU Cooler, a methionine-free protein formula containing L-cysteine, to provide nutrition that she cannot obtain from her low-protein diet. (Id. at PageID.301.) She drinks four HCU Coolers orally each day, and “tube feeding is not necessary in [her] case.” (Id.) Use of “a methionine-free amino acid formula

supplying the other amino acids,” such as HCU Cooler, is the recognized medical standard of care in treating HCU. (Id. at PageID.310.) Plaintiff submitted claims for Medicare reimbursement for HCU Cooler covering the periods December 18, 2018–January 12, 2019; February 18, 2019–March 17, 2019; March 21, 2019–April 20, 2019; and August 12, 2019–September 11, 2019, totaling at least $22,034.70. (Id. at PageID.129, 331, 338–39.) CGS Administrators, LLC (CGS), the Medicare Administrative Contractor (MAC), denied the claim initially and on redetermination. CGS concluded that the claims were not covered by Medicare and that Kelly was responsible for the cost of the HCU Cooler. (Id. at PageID.280–82.) On December 10, 2019, Plaintiff requested reconsideration of the denial by a Qualified Independent Contractor (QIC). (Id. at PageID.327.) On February 3, 2020, MAXIMUS Federal Services, the QIC, denied coverage on the basis that the enteral formula, or HCU Cooler, does not meet Medicare coverage guidelines for parenteral/enteral nutrition. The QIC also found the supplier, OCT Pharmacy LLC, responsible for the charges. (Id. at PageID.229– 33.) On March 26, 2020, Plaintiff requested a hearing before an Administrative Law Judge (ALJ).

(Id. at PageID.216–17.) Following a May 4, 2020 telephone hearing, (id. at PageID.375–91), ALJ Lynette Gohr issued an unfavorable decision on May 15, 2020, concluding that Kelly’s HCU Cooler did not meet the coverage requirements for enteral nutrition and that Kelly was responsible for the non-covered costs. (Id. at PageID.370–74.) On July 1, 2020, Plaintiff requested that the Medicare Appeals Council (Appeals Council) review ALJ Gohr’s decision. (Id. at PageID.125.) The Appeals Council issued a decision on December 22, 2020, adopting ALJ Gohr’s decision. Therefore, Plaintiff fully exhausted her administrative appeals. See 42 C.F.R. § 405.904. B. Statutory and Regulatory Provisions at Issue The Medicare Act, set forth in Title XVIII of the Social Security Act, 42 U.S.C. § 1395 et seq., was enacted in 1965 to establish a national program of health insurance for the aged and

disabled. At issue in this case is Medicare Part B, which provides coverage for “medical and other health services.” 42 U.S.C. § 1395k(a)(1). The Act “does not contain a comprehensive list” of items or services covered or excluded by Medicare. 68 Fed. Reg. 55634, 55635 (Sept. 26, 2003). “Rather, it lists categories of items and services, and vests in the Secretary the authority to make determinations about which specific items and services within these categories can be covered under the Medicare program.” Id. Payment depends upon a determination “that a service meets a benefit category, is not specifically excluded from coverage, and the item or service is ‘reasonable and necessary.’” Id.; see also 42 U.S.C. § 1395y(a)(1)(A). The benefit category at issue covers “prosthetic devices (other than dental) which replace all or part of an internal body organ (including colostomy bags and supplies directly related to colostomy care), including replacement of such devices . . . .” 42 U.S.C. § 1395x(s)(8). To determine whether an item or service is reasonable and necessary under the Act and to promote consistency in coverage determinations, Congress has authorized the Secretary to issue generally

applicable rules through National Coverage Determinations (NCD). 42 U.S.C. § 1395y(l)(6)(A). An NCD is a determination “whether or not a particular item or service is covered nationally under . . . [Medicare].” 42 U.S.C. § 1395ff(f)(1)(B); 42 C.F.R. § 405.1060(a)(1). NCDs are binding at all levels during administrative claim adjudication. Id. at § 405.1060(a)(4). The NCD at issue is 180.2 (retired January 1, 2022) for Enteral and Parental Nutritional Therapy.3 NCD 180.2 applies to individuals “who, because of chronic illness or trauma, cannot be sustained through oral feeding” and “must rely on either enteral or parenteral nutritional therapy, depending upon the particular nature of their medical condition.”4 Id. Enteral nutrition therapy is covered if the individual meets the requirements of the prosthetic device benefit under

Part B.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Waters v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/waters-v-secretary-of-health-and-human-services-miwd-2022.